Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Movers & Shakers Image

Movers & Shakers

ALM Staff & Law Journal Newsletters

Who's going where; who's doing what.

Verdicts Image

Verdicts

ALM Staff & Law Journal Newsletters

Recent rulings of importance to you and your practice.

Drug & Device News Image

Drug & Device News

ALM Staff & Law Journal Newsletters

The most recent news for your review.

Features

Med Mal News Image

Med Mal News

ALM Staff & Law Journal Newsletters

Recent events you need to know.

Features

Trial Tactics in Psychiatrist Liability Cases Image

Trial Tactics in Psychiatrist Liability Cases

Joshua D. Koskoff

The average juror may not be aware of the extent of mental-health professionals' duty to protect innocent third parties from their dangerous patients, and they may be reluctant to hold these professionals responsible. Following are some strategies that will help to get the plaintiff's point of view across to the fact finder.

Experimental Drugs and the Compassionate Use Doctrine Image

Experimental Drugs and the Compassionate Use Doctrine

Janice G. Inman

While gaining access to drugs not yet approved by the FDA can be a difficult task, many people will go to nearly any lengths to get them, even suing a drug manufacturer to force it to provide them the drug. That's what happened in the case of <i>Gunvalson v. PTC Therapeutics Inc.</i>, a case recently overturned on appeal.

Features

Spoliation in a Medical Malpractice Case Image

Spoliation in a Medical Malpractice Case

Kim M. Ruder

Spoliation in the context of a medical malpractice case can raise many issues for lawyers representing doctors and hospitals. These issues can often be overlooked until it is too late to repair the damage done.

Features

<b>BREAKING NEWS:</b> Eli Lilly to Pay $1.42 Billion to Settle Zyprexa Marketing Suits Image

<b>BREAKING NEWS:</b> Eli Lilly to Pay $1.42 Billion to Settle Zyprexa Marketing Suits

Shannon P. Duffy

Eli Lilly &amp; Co. will pay a combined $1.42 billion, including the largest criminal fine in history ' $515 million ' to settle charges that it illegally marketed the anti-psychotic drug Zyprexa for off-label use, federal prosecutors announced on Jan. 15.

Movers & Shakers Image

Movers & Shakers

ALM Staff & Law Journal Newsletters

Who's doing what; who's going where.

Verdicts Image

Verdicts

ALM Staff & Law Journal Newsletters

Recent rulngs of importance to you and your practice.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • Strategy vs. Tactics: Two Sides of a Difficult Coin
    With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
    Read More ›
  • Major Differences In UK, U.S. Copyright Laws
    This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
    Read More ›
  • Strategic Uses of a Rule 2004 Exam
    While most bankruptcy practitioners are familiar with the basic concepts behind the Rule 2004 exam, some are less familiar with the procedural intricacies of obtaining, conducting, and responding to the exam ' intricacies that often involve practices and procedures adapted from civil discovery that are beyond the scope of pure bankruptcy practice. This article explains.
    Read More ›